Centre approves increase in production of Remdesivir and reducing its prices


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
ED has been directed to act against black marketing of Remdesivir

The government has decided to increase the production and supply of Remdesivir and also to reduce its prices in the country. It has approved seven additional sites having a production capacity of 10 Lakh vials per month to six manufacturers.

The current total installed capacity of the seven manufacturers of Remdesivir in the country is 38 lakh 80 thousand vials per month. Minister of State for Chemicals and Fertilizers Mansukh Mandaviya today reviewed the issue of availability of Remdesivir in the country.

The Ministry said, another 30 lakh vials per month production is lined up. This will ramp up the production capacity for manufacturing to around 78 lakh vials per month. Earlier the government had prohibited exports of injection Remdesivir to increase the supply in the Domestic Market.


The Ministry said, manufacturers of Remdesivir have volunteered to reduce the price to less than 3,500 by the end of this week, to support the efforts to Fight against COVID. The manufactures have been directed to give priority to fulfil hospital and institutional level supplies.

Enforcement Authorities of States and Central Government have also been directed by Drugs Controller General of India, DCGI to take immediate action on the incidence of black-marketing, hoarding and overcharging of Remdesivir. The Ministry said National Pharmaceutical Pricing Authority is continuously monitoring the availability of Remdesivir.

Tags : #CentralGovernment #Remdesivir #DCGI #ED #EnforcementDiectorate #RemdesivirBlackMarketing

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

Vahan.ai Advances Multilingual AI Recruitment with NVIDIA NemotronAugust 25, 2026
Vahan.ai Advances Multilingual AI Recruitment with NVIDIA NemotronAugust 25, 2026
Beyond Basic Baby Care: Addressing the Monsoon Surge in Infant Skin Concerns with Salve’s Littloo RangeAugust 25, 2026
100+ Bengaluru Clinics Use QR678® as Indian Hair Regeneration Platform Adds New Patent and Expands GloballyAugust 25, 2026
Healthcare Innovation in India: Real Stories That Are Reshaping the Future of MedicineAugust 25, 2026
Generative AI in Indian Hospitals: Where It Is Actually Making a Difference in 2026August 25, 2026
High Uric Acid and Gout: Symptoms, Causes, Diet, Tests, and Treatment ExplainedAugust 24, 2026
Vitamin D Deficiency in India: Symptoms, Causes, Tests, Treatment and PreventionAugust 24, 2026
SRM College of Pharmacy Hosts Two-Day National Pharmaceutical ConferenceAugust 21, 2026
Atomy India Joins Hands with the Paralympic Committee of India as OfficialNutrition and Wellness PartnerAugust 21, 2026
Thumbay International Pathway - MD Program with Installments and a Direct Route to Residency in RomaniaAugust 21, 2026
THIP wins ‘Breakthrough Digital Patient Education Initiative’ award at India Vaccine Leaders Conclave in PuneAugust 21, 2026
Three Watermelons, a Mannequin Head and a PS5: What India Left Behind on Intercity BusesAugust 21, 2026
Evaluating Thyroid Nodules: Fine Needle Aspiration Cytology (FNAC) and Bethesda ClassificationAugust 21, 2026
Clinical Approaches to Acute Kidney Injury (AKI): Biomarkers, Staging, and Renal Replacement TherapyAugust 21, 2026
Diabetes Care in India: Understanding the Crisis, Bridging the Gaps, and Building a Healthier FutureAugust 21, 2026
Diabetes Management: Lifestyle Changes That Make a Real DifferenceAugust 21, 2026
TagMango introduces New AI capabilities for creator businesses at RISE 2026August 20, 2026
AFib: The Irregular Heartbeat We Need to Stop IgnoringAugust 20, 2026
Nanavati Max Launches Dedicated Cancer Helpline to Support Patients and Families In Their Cancer JourneyAugust 20, 2026